Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
Nako Maishi(Hokkaido University), Kyoko Hida(Hokkaido University), Noritaka Ohga(Sapporo University), Masanobu Shindoh(Hokkaido University), Hiroko Nagao‐Kitamoto(The University of Osaka), Yasuhiro Hida(Hokkaido University), Yusuke Ohba(University of Tsukuba), Taisuke Kawamoto(Hokkaido University), Kosuke Akiyama(Kagawa University), Akinobu Taketomi(Hokkaido University), Nobuo Inoue(Hokkaido University), Kazuyuki Yamamoto(Hokkaido University), Junichi Hamada(Hokkaido University), Mohammad Towfik Alam(Hokkaido University)
Cited by 136
Related Papers
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244